Cargando…

A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach

Development of more potent antituberculosis agents is as a result of emergence of multidrug resistant strains of M. tuberculosis. Novel compounds are usually synthesized by trial approach with a lot of errors, which is time consuming and expensive. QSAR is a theoretical approach, which has the poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Adeniji, Shola Elijah, Uba, Sani, Uzairu, Adamu, Arthur, David Ebuka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521565/
https://www.ncbi.nlm.nih.gov/pubmed/31186969
http://dx.doi.org/10.1155/2019/5173786
_version_ 1783418988149080064
author Adeniji, Shola Elijah
Uba, Sani
Uzairu, Adamu
Arthur, David Ebuka
author_facet Adeniji, Shola Elijah
Uba, Sani
Uzairu, Adamu
Arthur, David Ebuka
author_sort Adeniji, Shola Elijah
collection PubMed
description Development of more potent antituberculosis agents is as a result of emergence of multidrug resistant strains of M. tuberculosis. Novel compounds are usually synthesized by trial approach with a lot of errors, which is time consuming and expensive. QSAR is a theoretical approach, which has the potential to reduce the aforementioned problem in discovering new potent drugs against M. tuberculosis. This approach was employed to develop multivariate QSAR model to correlate the chemical structures of the 2,4-disubstituted quinoline analogues with their observed activities using a theoretical approach. In order to build the robust QSAR model, Genetic Function Approximation (GFA) was employed as a tool for selecting the best descriptors that could efficiently predict the activities of the inhibitory agents. The developed model was influenced by molecular descriptors: AATS5e, VR1_Dzs, SpMin7_Bhe, TDB9e, and RDF110s. The internal validation test for the derived model was found to have correlation coefficient (R(2)) of 0.9265, adjusted correlation coefficient (R(2) adj) value of 0.9045, and leave-one-out cross-validation coefficient (Q_cv(∧)2) value of 0.8512, while the external validation test was found to have (R(2) test) of 0.8034 and Y-randomization coefficient (cR_p(∧)2) of 0.6633. The proposed QSAR model provides a valuable approach for modification of the lead compound and design and synthesis of more potent antitubercular agents.
format Online
Article
Text
id pubmed-6521565
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-65215652019-06-11 A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach Adeniji, Shola Elijah Uba, Sani Uzairu, Adamu Arthur, David Ebuka Adv Prev Med Research Article Development of more potent antituberculosis agents is as a result of emergence of multidrug resistant strains of M. tuberculosis. Novel compounds are usually synthesized by trial approach with a lot of errors, which is time consuming and expensive. QSAR is a theoretical approach, which has the potential to reduce the aforementioned problem in discovering new potent drugs against M. tuberculosis. This approach was employed to develop multivariate QSAR model to correlate the chemical structures of the 2,4-disubstituted quinoline analogues with their observed activities using a theoretical approach. In order to build the robust QSAR model, Genetic Function Approximation (GFA) was employed as a tool for selecting the best descriptors that could efficiently predict the activities of the inhibitory agents. The developed model was influenced by molecular descriptors: AATS5e, VR1_Dzs, SpMin7_Bhe, TDB9e, and RDF110s. The internal validation test for the derived model was found to have correlation coefficient (R(2)) of 0.9265, adjusted correlation coefficient (R(2) adj) value of 0.9045, and leave-one-out cross-validation coefficient (Q_cv(∧)2) value of 0.8512, while the external validation test was found to have (R(2) test) of 0.8034 and Y-randomization coefficient (cR_p(∧)2) of 0.6633. The proposed QSAR model provides a valuable approach for modification of the lead compound and design and synthesis of more potent antitubercular agents. Hindawi 2019-05-02 /pmc/articles/PMC6521565/ /pubmed/31186969 http://dx.doi.org/10.1155/2019/5173786 Text en Copyright © 2019 Shola Elijah Adeniji et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Adeniji, Shola Elijah
Uba, Sani
Uzairu, Adamu
Arthur, David Ebuka
A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
title A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
title_full A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
title_fullStr A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
title_full_unstemmed A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
title_short A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
title_sort derived qsar model for predicting some compounds as potent antagonist against mycobacterium tuberculosis: a theoretical approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521565/
https://www.ncbi.nlm.nih.gov/pubmed/31186969
http://dx.doi.org/10.1155/2019/5173786
work_keys_str_mv AT adenijisholaelijah aderivedqsarmodelforpredictingsomecompoundsaspotentantagonistagainstmycobacteriumtuberculosisatheoreticalapproach
AT ubasani aderivedqsarmodelforpredictingsomecompoundsaspotentantagonistagainstmycobacteriumtuberculosisatheoreticalapproach
AT uzairuadamu aderivedqsarmodelforpredictingsomecompoundsaspotentantagonistagainstmycobacteriumtuberculosisatheoreticalapproach
AT arthurdavidebuka aderivedqsarmodelforpredictingsomecompoundsaspotentantagonistagainstmycobacteriumtuberculosisatheoreticalapproach
AT adenijisholaelijah derivedqsarmodelforpredictingsomecompoundsaspotentantagonistagainstmycobacteriumtuberculosisatheoreticalapproach
AT ubasani derivedqsarmodelforpredictingsomecompoundsaspotentantagonistagainstmycobacteriumtuberculosisatheoreticalapproach
AT uzairuadamu derivedqsarmodelforpredictingsomecompoundsaspotentantagonistagainstmycobacteriumtuberculosisatheoreticalapproach
AT arthurdavidebuka derivedqsarmodelforpredictingsomecompoundsaspotentantagonistagainstmycobacteriumtuberculosisatheoreticalapproach